Shah Rajeev M. Insider Trades

Insider Trading History

Track insider trading activity for Shah Rajeev M.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $0 0 shares
Last Trade
Jun 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$66k 60,000 shares
$1.10
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $0 0 shares
Last Trade
Jun 06, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$6.56M 5,914,252 shares
$1.11
$1.10
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $34.5k 16,500 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 16,500 shares
$1.82
$2.09
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $0 0 shares
Last Trade
Oct 14, 2022 Sale (Tender)Reported as Tender on SEC Form 4.
$30.2M 1,511,425 shares
$20.01
$20.01
Forma Therapeutics Holdings
Forma Therapeutics Holdings FMTX
Director
Holding Value $0 0 shares
Last Trade
Oct 14, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$135k 6,750 shares
$20.01
$20.01
Wave Life Sciences
Wave Life Sciences WVE
Director
Holding Value $128k 21,000 shares
Last Trade
Aug 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.5k 21,000 shares
$3.50
$6.09
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $15.7M 3,773,417 shares
Last Trade
Aug 03, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.5k 1,809 shares
$7.48
$4.17
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $15.7M 3,771,608 shares
Last Trade
Jul 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$65.5k 8,281 shares
$7.91
$4.17
89bio
89bio ETNB
Director
Holding Value $115M 7,782,669 shares
Last Trade
Jul 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10M 2,816,900 shares
$3.55
$14.84
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $15.6M 3,748,389 shares
Last Trade
Jun 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.41k 302 shares
$7.99
$4.17
Aerovate Therapeutics
Aerovate Therapeutics AVTE
Director
Holding Value $33.5k 12,500 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.36M 12,500 shares
$429.10
$2.68
Wave Life Sciences
Wave Life Sciences WVE
Director
Holding Value $43.2M 7,093,656 shares
Last Trade
Jun 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.5M 7,093,656 shares
$1.91
$6.09
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 25,000 shares
$3.59
$2.29
Janux Therapeutics
Janux Therapeutics JANX
Director
Holding Value $172k 12,500 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 12,500 shares
$10.73
$13.76
Vor Biopharma
Vor Biopharma VOR
Director
Holding Value $242k 16,911 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 16,911 shares
$4.26
$14.32
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $15.4M 3,686,663 shares
Last Trade
Jun 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$158k 20,000 shares
$7.90
$4.17
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $394k 14,500 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$78k 14,500 shares
$5.38
$27.18
Icosavax
Icosavax ICVX
Director
Holding Value $84.9k 5,543 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.6k 5,543 shares
$6.25
$15.31
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $31.4k 15,000 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1k 15,000 shares
$2.14
$2.09
ITeos Therapeutics
ITeos Therapeutics ITOS
Director
Holding Value $178k 17,538 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 17,538 shares
$18.78
$10.15

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up